381 related articles for article (PubMed ID: 21195581)
1. Lung involvement in systemic sclerosis.
Hassoun PM
Presse Med; 2011 Jan; 40(1 Pt 2):e3-e17. PubMed ID: 21195581
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and management approaches for scleroderma lung disease.
Schoenfeld SR; Castelino FV
Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
5. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
7. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
8. Lung disease in systemic sclerosis (scleroderma).
Bolster MB; Silver RM
Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
[TBL] [Abstract][Full Text] [Related]
9. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
10. [Lung involvement in systemic sclerosis].
Posa M; Stelle M; Lador F; Chizzolini C
Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
[TBL] [Abstract][Full Text] [Related]
11. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
12. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
13. Therapy of pulmonary arterial hypertension in systemic sclerosis: an update.
Denton CP; Nihtyanova SI
Curr Rheumatol Rep; 2007 May; 9(2):158-64. PubMed ID: 17502047
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Hypertension in Systemic Sclerosis.
Cullivan S; Cronin E; Gaine S
Semin Respir Crit Care Med; 2024 Jun; 45(3):411-418. PubMed ID: 38531379
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide therapy for scleroderma.
Akesson A
Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
[TBL] [Abstract][Full Text] [Related]
16. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary involvement in systemic sclerosis.
Shahin AA
Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
[TBL] [Abstract][Full Text] [Related]
18. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
[TBL] [Abstract][Full Text] [Related]
19. An update on the evaluation and management of pulmonary hypertension in scleroderma.
Coghlan JG; Schreiber B
Curr Rheumatol Rep; 2012 Feb; 14(1):1-10. PubMed ID: 22215445
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis-associated pulmonary arterial hypertension.
Le Pavec J; Humbert M; Mouthon L; Hassoun PM
Am J Respir Crit Care Med; 2010 Jun; 181(12):1285-93. PubMed ID: 20194816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]